no image available Dickens & Co. "Hope Amidst the Shadows: The Safety of Sorafenib in Hepatocellular Carcinoma Patients" "Unlocking the Promise of Sorafenib in Patients with Advanced Liver Cancer, Without Compromising Their Well-being" Price: 22.00€